Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients.
Lee V, Parkinson R, Zahurak M, Cope L, Cercek A, Verheul H, Gootjes E, Lenz HJ, Iqbal S, Jones P, Baylin S, Rami V, Ahuja N, El Khoueiry A, Azad NS. Lee V, et al. Among authors: gootjes e. Int J Cancer. 2024 May 15;154(10):1794-1801. doi: 10.1002/ijc.34845. Epub 2024 Feb 5. Int J Cancer. 2024. PMID: 38312102 Clinical Trial.
Treatment of locally advanced rectal cancer and synchronous liver metastases: multicentre comparison of two treatment strategies.
van Rees JM, Krul MF, Kok NFM, Grünhagen DJ, Kok END, Nierop PMH, Havenga K, Rutten H, Burger JWA, de Wilt JHW, Hagendoorn J, Peters FP, Buijsen J, Tanis PJ, Verhoef C, Kuhlmann KFD; Dutch Stage IV Rectal Cancer Group. van Rees JM, et al. Br J Surg. 2023 Aug 11;110(9):1049-1052. doi: 10.1093/bjs/znad013. Br J Surg. 2023. PMID: 36821778 Free PMC article. No abstract available.
Validation of simplified uptake measures against dynamic Patlak Ki for quantification of lesional 89Zr-Immuno-PET antibody uptake.
Wijngaarden JE, Huisman MC, Jauw YWS, van Dongen GAMS, Greuter HNJM, Schuit RC, Cleveland M, Gootjes EC, Vugts DJ, Menke-van der Houven van Oordt CW, Boellaard R. Wijngaarden JE, et al. Among authors: gootjes ec. Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):1897-1905. doi: 10.1007/s00259-023-06151-1. Epub 2023 Feb 23. Eur J Nucl Med Mol Imaging. 2023. PMID: 36820891 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 38253952
89Zr-cetuximab PET imaging in patients with advanced colorectal cancer.
Menke-van der Houven van Oordt CW, Gootjes EC, Huisman MC, Vugts DJ, Roth C, Luik AM, Mulder ER, Schuit RC, Boellaard R, Hoekstra OS, van Dongen GA, Verheul HM. Menke-van der Houven van Oordt CW, et al. Oncotarget. 2015 Oct 6;6(30):30384-93. doi: 10.18632/oncotarget.4672. Oncotarget. 2015. PMID: 26309164 Free PMC article. Clinical Trial.
A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan.
Lee V, Wang J, Zahurak M, Gootjes E, Verheul HM, Parkinson R, Kerner Z, Sharma A, Rosner G, De Jesus-Acosta A, Laheru D, Le DT, Oganesian A, Lilly E, Brown T, Jones P, Baylin S, Ahuja N, Azad N. Lee V, et al. Among authors: gootjes e. Clin Cancer Res. 2018 Dec 15;24(24):6160-6167. doi: 10.1158/1078-0432.CCR-18-0421. Epub 2018 Aug 10. Clin Cancer Res. 2018. PMID: 30097434 Clinical Trial.
Safety and Feasibility of Additional Tumor Debulking to First-Line Palliative Combination Chemotherapy for Patients with Multiorgan Metastatic Colorectal Cancer.
Gootjes EC, van der Stok EP, Buffart TE, Bakkerus L, Labots M, Zonderhuis BM, Tuynman JB, Meijerink MR, van de Ven PM, Haasbeek CJA, Ten Tije AJ, de Groot JB, Hendriks MP, van Meerten E, Nuyttens JJME, Grunhagen DJ, Verhoef C, Verheul HMW; ORCHESTRA study group. Gootjes EC, et al. Oncologist. 2020 Aug;25(8):e1195-e1201. doi: 10.1634/theoncologist.2019-0693. Epub 2020 Jun 16. Oncologist. 2020. PMID: 32490570 Free PMC article. Clinical Trial.
27 results